SynAct Pharma Signs First Commercial Partner for Resomelagon
SynAct Pharma has signed a 50/50 commercial partnership for resomelagon.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
SynAct Pharma Signs First Commercial Partnership for Resomelagon
SynAct Pharma has signed its first commercial partnership agreement for resomelagon with a leading Brazilian pharmaceutical company.